Symbols

APVO

Aptevo Therapeutics·NASDAQ

--(--)

APVO Profile

Aptevo Therapeutics Inc.

A biotechnology company developing novel immunotherapies for cancer and autoimmune diseases

Industry

Biological Technology

Established Date

Listing Date

08/01/2016

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.AptevoTherapeutics.com

Security Type

Common stock

Office address

2401 4th Avenue Suite 1050 Seattle Washington 98121

Business

Introduction

Aptevo Therapeutics Inc., was incorporated in Delaware in February 2016. The company is a clinical-stage R&D biotechnology company focused on developing novel immunotherapy candidates for the treatment of different forms of cancer. The company has developed two multifunctional platform technologies for the rational design of precision immunomodulatory drugs.